Lyta joins Naira Marley’s record label, Marlian Music

Lyta, a musician formerly signed to Olamide’s record label, YBNL, has joined Marlian Music, Naira Marley’s record label.

Just one year after joining Doro Music and releasing his popular single, ‘Monalisa,’ Lyta has again moved from the label to join Naira Marley’s Marlian Records. He becomes the fifth act to sign with Marlian Records after Zinoleesky, Mohbad and two other acts.

The news was disclosed on Tuesday when Marley took to his Twitter page to share a picture of Lyta with a document that appears to be a record deal, with the caption: “Welcome to MarlianMusic Lyta.”

ABOKIFX GIVES YOU LIVE RATES OF DOLLAR TO NAIRA TODAY

Reacting to the development, Lyta wrote: “I’m so excited to be joining my new family Marlian music, thank you my President @nairamarley for giving me this amazing opportunity.”

ON LEAVING YBNL

Explaining why he left Olamide‘s record label in 2019, Lyta had said he was given a music release calendar which was inconsistent with how often he intended dropping new songs.

“When we want to drop new songs, we do so in a group of five. I was dropping my songs and they were talking about a calendar of some sort that I knew nothing about,” he said.

“I couldn’t always have to wait that long before dropping songs for my fans. That was why I made the move to leave the label. Olamide treats me well. He takes me like a son and taught me lots of stuff, told me I had to hustle. While I’ve been there, I’ve been okay with the family. But for the good of my music career, I decided to move.”

HAVE YOU READ, DSS invites Mailafia for questioning for accusing gov of sponsoring Boko Haram

“I don’t have any deal with YBNL or Olamide. Olamide saw me on the street and helped me. I don’t have any written contract with him… YBNL and Olamide will always be part of my story.

“Yes, I was getting benefits. They used to pay me for shows. Sometimes N80,000, N60,000. But when I dropped my songs, ‘Temi’ and ‘Selfmade,’ I didn’t get anything.”

YOU MIGHT ALSO LIKE, Russia COVID-19 vaccine;Experts recommend for people between 18 and 60 years